Observational studyActa oncologica (Stockholm, Sweden)2026

FIN-EGFRprint: a Finnish real-world study on treatments and outcomes in advanced NSCLC with common EGFR mutations.

Aija Knuuttila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.